Streptococcal B vaccine conjugate - Baxter International
Latest Information Update: 12 Oct 2006
At a glance
- Originator Baxter International; Brigham and Womens Hospital; Harvard University
- Class Conjugate vaccines; Glycoconjugates; Polysaccharides; Streptococcal vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Streptococcal infections
Most Recent Events
- 16 Aug 2002 Preclinical trials in Streptococcal infections in USA (unspecified route)
- 27 Jun 2000 North American Vaccine has been acquired by and merged into Baxter International
- 30 Jun 1999 North American Vaccine has been awarded a US patent covering its unique Streptococcal B vaccine conjugate